Amplia Therapeutics Ltd - Amplia Provides Updated Investor Presentation
Amplia Therapeutics Ltd (ASX:ATX)

Amplia Provides Updated Investor Presentation


What's happened?

Amplia Therapeutics Limited (ASX: ATX, “Amplia”) has released a new investor presentation which provides an update on the Company’s technology and its near-term and mid-term plans as it moves towards initiating its first clinical trial later this year.

To see the presentation in full, please click the link below.

CEO's Summary

John Lambert

“The company has made extraordinary progress over the last 12 months and it is very exciting to be on the cusp of commencing the clinical development of AMP945. The Phase 1 trial we plan to conduct has been designed to unlock the commercial opportunities provided by AMP945 and we expect to hit several key development milestones over the next 12-18 months”.

John Lambert
CEO, Amplia Therapeutics Ltd

Download Announcement

View this announcement as well as our full profile on the company.

How do I invest?

Considering investing in Amplia Therapeutics Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:ATX

    On your online investment platform search for the stock ticker code ASX:ATX to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.